Pharmacokinetic studies of lacosamide in humans show that it is minimally bound to plasma proteins, has approximately a 13-h half-life, is excreted renally (as unchanged drug or metabolites ...

Lacosamide 10mg/mL; soln for IV infusion. The precise mechanism by which Vimpat exerts its antiepileptic effects in humans remains to be fully elucidated. In vitro electrophysiological studies ...

Lacosamide 10mg/mL; strawberry-flavored; contains phenylalanine 0.32mg/20mL. The precise mechanism by which Vimpat exerts its antiepileptic effects in humans remains to be fully elucidated. In ...

Glenmark’s lacosamide oral solution, 10 mg/mL is bioequivalent and therapeutically equivalent to the reference listed drug, Vimpat Oral solution ... dermatology and oncology. The company has 11 ...

Shares of Glenmark Pharma were higher by up to 2% in early trade on December 16 after the company's US business launched its own version of the anti-epileptic drug Lacosamide, which is the ...